Tove Myrback-Hegelund
AstraZeneca R&D
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non-interventional study in Kenya.
Journal: Diabetes, obesity & metabolism
Published: December 22, 2023
Estimation of Equipotent Doses for Anti-Inflammatory Effects of Prednisolone and AZD9567, an Oral Selective Nonsteroidal Glucocorticoid Receptor Modulator.
Journal: CPT: pharmacometrics & systems pharmacology
Published: December 27, 2019
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials.
Journal: The Lancet. Rheumatology
Published: September 09, 2019
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: April 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
Journal: Journal of medicinal chemistry
Published: February 10, 2018
AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNFα with Minimal Systemic Exposure.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 06, 2017
Gene expression analysis of membrane transporters and drug-metabolizing enzymes in the lung of healthy and COPD subjects.
Journal: Pharmacology research & perspectives
Published: April 24, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026